Aspen Pharmacare gets $700 mln loan from global financial institutions

PUBLISHED: Wed, 30 Jun 2021 14:58:32 GMT

JOHANNESBURG, June 30 (Reuters) – South African pharmaceutical company Aspen Pharmacare said on Wednesday it had received a loan of 600 million euro ($711.84 million) from global finance institutions to help to refinance existing loans and to develop vaccines.

International Finance Institution (IFC), the private sector arm of the World Bank said in a statement that the loan will “refinance existing debt and strengthen the company’s balance sheet, supporting Aspen’s operations including production of vaccines.”

Aspen is sourcing COVID-19 vaccine ingredients from Johnson & Johnson to package the vaccines in South Africa, a process known as fill and finish. ($1 = 0.8429 euros) (Reporting by Promit Mukherjee. Editing by Jane Merriman)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.